• Ave. 31 No. 15802 between 158 y 190, Cubanacán, Playa, Havana. C.P. 11600, P.O. Box 6162
  • webmaster@cigb.edu.cu
  • (53) 7-2504101; (53) 7-2716022

BioNCiD 2025

Loading Events

Invitation

We are pleased to invite you to attend the International Congress Biopharm Nonclinical Development, BioNCiD 2025.

This event aims to bring together experts, academics and industry professionals to discuss the latest advances in research for the nonclinical development of innovative biopharmaceuticals, promoting compliance with the 3Rs and the culture of care.

We look forward to your valuable presence to promote the updating and advancement of scientific research in these fields.

 

Topics

  1. Nonclinical development programs for drugs and biopharmaceuticals
  2. Advances in pharmacokinetics and toxicology
  3. Trends in the evaluation of drug-drug interactions, drug-biotechnological products and microbiota
  4. Update of the nonclinical regulatory framework
  5. Staff training and accreditation of facilities
  6. Institutional Animal Care and Use Committee (IACUC) and its role in nonclinical development
  7. Animal and human welfare: behavioral management and implementation of culture of care according to nonclinical regulatory requirements and application of 3Rs
  8. Domestic cage monitoring technologies, improved nonclinical to clinical translation
  9. Animal models: development and use, challenges and perspectives
  10. In silico, mathematical and other alternative nonclinical development methods

Sponsorship packages

  • Bronze package 3000 USD: 1 person free of registration fee, possibility of including a conference within the scientific program, the name and logo of the company will be used and displayed in all promotions of the congress.
  • Silver package 4000 USD: 2 persons free of registration fee, possibility of including a conference within the scientific program, the name and logo of the company will be used and displayed in all promotions of the Congress.
  • Gold package 5000 USD: 3 persons free of registration fee, possibility of including a conference within the scientific program and one plenary lecture at the beginning of the sessions with an extended time, the name and logo of the company will be used and displayed in all promotions of the Congress.
  • Platinum package 6000 USD: 4 persons free of registration fee, possibility of including a conference within the scientific program and one plenary lecture at the beginning of the sessions with an extended time, the name and logo of the company will be used and displayed in all promotions of the Congress.
  • Other sponsorship alternatives: Any of these alternatives include recognition as a sponsor with the use of the company or organization logo in the activities of the Congress and web site.

Details

Start:
25 mayo 2025
End:
29 mayo 2025
Website:
/en/event/international-congress-biopharm-nonclinical-development-bioncid-2025

Venue

Iberostar Selection Varadero Resort
Varadero
Matanzas, Cuba

Documentation

Organizers

Jorge Castro Velzaco, PhD.
Phone:
(+53) 72716022, ext. 2300
Email:
jorge.castro@cigb.edu.cu
Lizet Aldana Velazco, MSc.
Phone:
(+53)7216022, ext. 2308
Email:
lizet.aldana@cigb.edu.cu
MSc. Osvaldo Reyes Acosta
Phone:
(53) 7250-4644 (53) 7271-6022 Ext. 1144
Email:
osvaldo.reyes@cigb.edu.cu

Scientific Comittee

Jorge Castro Velzaco, PhD.
Phone:
(+53) 72716022, ext. 2300
Email:
jorge.castro@cigb.edu.cu
Lizet Aldana Velazco, MSc.
Phone:
(+53)7216022, ext. 2308
Email:
lizet.aldana@cigb.edu.cu

Abstract Instructions for Oral and Poster Presentations

Abstracts should be sent to the following e-mail address bioncid@cigb.edu.cu and will be published in the abstract book.

All abstracts submitted will be reviewed by the Organizing Committee for selection as an oral or poster presentation.

Poster presentations will be in electronic format.

Abstracts for both types of presentations should be sent by e-mail to the organizers as follows:

  1. Number of words: Abstracts should not exceed 300 words
  2. Font and spacing: Arial 10pt font and single line spacing
  3. Title: 130 characters (not including spaces) and bold
  4. Authors: Only last name, followed by space and initials (e.g., Castro R1,). The number of authors is not limited, but the principal author should be differentiated.
  5. Affiliations: Each author should be listed by department, institution, city, and country.
  6. Title alignment: centered
  7. Author list alignment: centered
  8. Author affiliation alignment: justified
  9. Abstract text alignment: justified
  10. Table, Figures and Graphics: Do not include Tables, Figures or Graphs
  11. Contact: Email address of the presenting author is required; this information should appear below the abstract.

Language: Abstracts of the Oral and Poster Presentations should be written in English

Abstract submission deadline: 31th March, 2025

Acceptance deadline: 30th April, 2025

Galería de imágenes